Sai Life Sciences secures SBTi validation for near-term climate targets
A view from inside Sai Life Sciences’ manufacturing facility in Bindar, Karnataka.
| Photo Credit:
Sai Life Sciences Limited
Near-term targets of Sai Life Sciences to cut Greenhouse Gas (GHG) emissions have been validated by the Science Based Targets initiative (SBTi), a corporate climate action organisation. SBTi enables companies and financial institutions worldwide to play their part in combating the climate crisis.
“As a contract research development and manufacturing organisation, our impact spans the entire pharmaceutical value chain which gives us both the responsibility and the opportunity to lead on sustainability. Achieving SBTi validation for our near-term science-based targets affirms that our climate commitments are grounded in science and aligned with global goals,’‘ Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said in a release.
In June 2023, the company joined SBTi and committed to setting company-wide near-term GHG reduction targets. Sai Life Sciences Limited has committed to reduce absolute scope 1 and 2 GHG emissions 58.8 per cent by FY2035 from a FY2024 base year.
More Like This
Published on August 20, 2025
